Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.67M Buy
144,912
+21,300
+17% +$791K 3.86% 13
2026
Q1
$4.95M Sell
123,612
-121,212
-50% -$5.74M 4.34% 12
2025
Q4
$11M Sell
244,824
-14,762
-6% -$683K 2.43% 15
2025
Q3
$11.6M Sell
259,586
-48,514
-16% -$2.32M 2.04% 22
2025
Q2
$14.8M Buy
308,100
+198,100
+180% +$8.62M 2.2% 23
2025
Q1
$4.42M Buy
+110,000
New +$4.63M 0.62% 28

Other funds holding QGEN

Nitorum Capital's QGEN Position: Q2 2026 in Review

Nitorum Capital increased its Qiagen (QGEN) stake by 17% in Q2 2026, buying an estimated $791K and bringing the position to 144,912 shares worth $5.67M. The position accounts for 3.86% of the portfolio, ranked #13.

Nitorum Capital first reported a position in QGEN in Q1 2025 and has held it in 6 quarters since. The position peaked at $14.8M in Q2 2025. 337 funds tracked by Wall St. Rank hold QGEN as of Q2 2026.

  • Nitorum Capital held 144,912 shares of Qiagen worth $5.67M as of Q2 2026.
  • Nitorum Capital bought 21,300 Qiagen shares in Q2 2026, an estimated $791K.
  • Qiagen made up 3.86% of Nitorum Capital's portfolio in Q2 2026, its #13 holding.
  • Nitorum Capital first reported a position in Qiagen in Q1 2025 and has held it in 6 quarters since.
  • Nitorum Capital's Qiagen position peaked at $14.8M in Q2 2025.
  • 337 funds tracked by Wall St. Rank held Qiagen as of Q2 2026.

Based on Nitorum Capital's 13F filing for Q2 2026, filed 14 Aug 2026.